Replimune said on Friday it plans to apply a third time for approval of its experimental skin cancer drug in the coming days ...
Hosted on MSN
Disclosure day - Emily Blunt is Margaret Clip
She has an ability like no other. Emily Blunt is Margaret in Disclosure Day. Only in theaters 06.12.26. We're not cattle. Southwest passenger at MIA told she's too large for seat Donald Trump's ...
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that following collaborative communications ...
At a Senate hearing, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Wednesday that he "had nothing to do” with the FDA’s decision to reject Replimune’s (REPL) lead candidate ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. If you haven't filed your tax return yet and don't have the time or ...
Replimune (REPL) has announced that it has no other option but to reduce its workforce and scale back U.S. manufacturing operations after the FDA on Friday declined to approve its lead asset, RP1, ...
The IRS shut down its direct filing program for 2026, but Free File, Fillable Forms, MilTax, and some private tools remain—if you know where to look. Here’s how to navigate the free options still ...
(NEXSTAR) – In 2025, nearly 300,000 Americans used a new electronic system to file their taxes directly with the IRS for free. In 2026, that’s no longer an option. IRS Direct File launched as a pilot ...
The Justice Department released a portion of the Jeffrey Epstein files to meet the Friday deadline established in a congressional bill with a series of downloadable files related to the convicted sex ...
The Files app has grown a lot since its introduction in iOS 11. While it's not quite Finder on Mac, it's more than enough to get work done. When the Files app first debuted with iOS 11 in 2017, it was ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results